Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019032877) MICELLES AND VESICLES FOR THE DELIVERY OF GLYCOPEPTIDES
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2019/032877 International Application No.: PCT/US2018/046078
Publication Date: 14.02.2019 International Filing Date: 09.08.2018
IPC:
A61K 8/11 (2006.01) ,A61K 8/14 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8
Cosmetics or similar toilet preparations
02
characterised by special physical form
11
Encapsulated compositions
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8
Cosmetics or similar toilet preparations
02
characterised by special physical form
14
Liposomes
Applicants:
ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA [US/US]; The University of Arizona, Tech Launch Arizona University Services Annex, 4th Floor P.O. Box 210300A Tucson, AZ 85721, US
Inventors:
POLT, Robin, L.; US
HANRAHAN, Dillon; US
SZABO, Lajos, Z.; US
HEIEN, Michael, L.; US
LIU, Chenxi; US
Agent:
NGUYEN, Quan; US
Priority Data:
62/543,36209.08.2017US
Title (EN) MICELLES AND VESICLES FOR THE DELIVERY OF GLYCOPEPTIDES
(FR) MICELLES ET VÉSICULES POUR LIBÉRATION DE GLYCOPEPTIDES
Abstract:
(EN) Methods for quality control and optimizing the formation and characterization of micelles, vesicles or other aggregates are described herein. Pharmaceutically relevant peptides may be modified to form giycopeptide surfactants which form micelles or other aggregates with another surfactant. Giycopeptide and giycolipid surfactants can aggregate to form particles that enhance drug delivery. The giycopeptide surfactants may be drugs or pro-drugs which are delivered via the micelles or other aggregated structures.
(FR) La présente invention concerne des procédés de contrôle qualité et d'optimisation de la formation et de la caractérisation de micelles, de vésicules ou d'autres agrégats. Les peptides pharmaceutiquement pertinents peuvent être modifiés pour former des tensioactifs glycopeptidiques qui forment des micelles ou d'autres agrégats avec un autre tensioactif. Des tensioactifs glycopeptidiques et glycolipides peuvent s'agréger pour former des particules qui améliorent l'administration de médicament. Les tensioactifs glycopeptidiques peuvent être des médicaments ou des promédicaments qui sont administrés par l'intermédiaire des micelles ou d'autres structures agrégées.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)